Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Scientific Reports|July 10, 2026
TAZ mediates enhancer reprogramming blocks neuronal differentiation in glioma stem-like cellsAlessandra Audia, Mahinur Mattohti, Visweswaran Ravikumar, et al.JCI Insight|June 2, 2022
Immune landscape of a genetically engineered murine model of glioma compared with human gliomaDaniel B Zamler, Takashi Shingu, Laura M Kahn, et al.Cell|September 21, 2010
DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APCKunal Rai, Sharmistha Sarkar, Talmage J Broadbent, et al.Molecular Cancer|September 26, 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphomaVivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.Stem Cell Reports|December 5, 2017
TRIM28 and Interacting KRAB-ZNFs Control Self-Renewal of Human Pluripotent Stem Cells through Epigenetic Repression of Pro-differentiation GenesUrszula Oleksiewicz, Marta Gładych, Ayush T Raman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2023
Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell CarcinomaAbdullah A Osman, Emre Arslan, Mason Bartels, et al.Cancers|March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and ImmunotherapyKang Qin, Kaiwen Wang, Shenduo Li, et al.Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.Cancer Discovery|July 4, 2012
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastomaGiannicola Genovese, Ayla Ergun, Sachet A Shukla, et al.Genes & Development|July 13, 2017
PRKCI promotes immune suppression in ovarian cancerSharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, et al.Pageof 9